Company Filing History:
Years Active: 2009
Title: Karine Breckpot: Innovator in Cancer Research
Introduction
Karine Breckpot is a prominent inventor based in Brussels, Belgium. She has made significant contributions to the field of cancer research, particularly through her innovative work on peptides that have therapeutic and diagnostic applications.
Latest Patents
Karine holds a patent for an isolated peptide that binds to HLA-Cw*07. This invention involves peptides consisting of amino acid sequences found in MAGEA3, which bind to HLA-Cw*07 molecules to form T cell epitopes. The therapeutic and diagnostic ramifications of this invention are substantial, as are the various products developed during its creation. She has 1 patent to her name.
Career Highlights
Karine is affiliated with the Ludwig Institute for Cancer Research Limited, where she continues her groundbreaking work in cancer immunotherapy. Her research focuses on the development of novel therapeutic strategies that harness the immune system to combat cancer.
Collaborations
Throughout her career, Karine has collaborated with esteemed colleagues such as Pierre Van Der Bruggen and Thierry Boon Falleur. These collaborations have further enriched her research and contributed to advancements in the field.
Conclusion
Karine Breckpot's innovative work in cancer research exemplifies the impact of scientific inquiry on healthcare. Her contributions through patents and collaborations highlight the importance of continued research in the fight against cancer.